Japanese drugmaker Takeda Pharmaceutical is set to receive an initial $20 million funding from the U.S. government to develop a vaccine for Zika. If the vaccine proves successful, the company could receive up to $312 million to manufacture the drug.
Takeda Gets $312 Million US Government Funding To Develop Zika Vaccine
Tech Times - 2 Sep 2016 17:29
Japanese drugmaker Takeda Pharmaceutical is set to receive an initial $20 million funding from the U.S. government to develop a vaccine for Zika. If the vaccine proves successful, the company could receive up to $312 million to manufacture the drug.
Share this Article
Recommended